Based on the HbA1c levels, the IL-1α levels significantly increased in the PD group that developed T2DM after 6 months of intervention (baseline: 0.6 (0.5–0.8), follow-up: 1.0 (0.9–1.4); p = 0.046). The gene discussed is IL1A; the disease is type 2 diabetes mellitus.